venBio Select Advisor »

Terns Pharmaceuticals shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-12-31 $176M 4.4M 40.40

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Structure Therapeutics Sponsored Ads (GPCR)
Avidity Biosciences Common (RNA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celcuity Common (CELC)
Apellis Pharmaceuticals Common (APLS)
Vera Therapeutics Common (VERA)
Spdr Series Trust - S&p Biotech Etf (XBI)
Xenon Pharmaceuticals Common (XENE)

View all positions for venBio Select Advisor

Top funds holding Terns Pharmaceuticals

BlackRock
Vanguard Group
Vivo Capital
Vestal Point Capital
venBio Select Advisor
Adage Capital Partners GP
Holocene Advisors
Franklin Resources
Lord, Abbett & Co
OrbiMed Advisors
Geode Capital Management
Ameriprise Financial
State Street Corporation
Acorn Capital Advisors
Nearwater Capital Markets

View all funds holding Terns Pharmaceuticals